Skip to main content
Log in

Natural course and prognosis of HLA-B27-positive oligoarthritis

  • Sero-Negative Arthritis
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Summary

A long-term follow-up of 119 patients with the descriptive diagnosis of B27-positive oligoarthritis showed that after a time between months to several years about half of the patients with this condition develop a definite disease of the seronegative spondarthritis group, especially ankylosing spondylitis. Another great part of the patients go into a complete and presumably persistent remission of their arthritis. After a follow-up time of 8 to 12 years, about 10% present a recurrent B27-associated oligoarthritis with some special clinical features. It is to be discussed whether this condition is a separate disease entity or still an abortive form of a well-known disease of the seronegative spondarthritis group.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schattenkirchner, M., Krüger, K. Natural course and prognosis of HLA-B27-positive oligoarthritis. Clin Rheumatol 6 (Suppl 2), 83–86 (1987). https://doi.org/10.1007/BF02203389

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02203389

Key words

Navigation